Loading…
A Comparative Study of the Effect of Labetalol and Remifentanil on Pain Control After Bariatric Surgery
Background: Finding the optimal combination of anesthetics to maintain hemodynamic stability during surgery can be challenging. Traditionally, strong opioid analgesics such as fentanyl and its newer analogs have been used. However, the use of narcotics is associated with certain side effects. Object...
Saved in:
| Published in: | Anesthesiology and pain medicine 2023-08, Vol.13 (4) |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Citations: | Items that this one cites |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | cdi_FETCH-LOGICAL-c1760-a76a988ad3a04483d68bea870dafd6fd58f4da285c96137cc4e5a6a79673106e3 |
| container_end_page | |
| container_issue | 4 |
| container_start_page | |
| container_title | Anesthesiology and pain medicine |
| container_volume | 13 |
| creator | Mohseni, Masood Farahmand Rad, Reza Jafarian, Ali Akbar Rostami, Mojtaba Khosravi, Niloofar |
| description | Background: Finding the optimal combination of anesthetics to maintain hemodynamic stability during surgery can be challenging. Traditionally, strong opioid analgesics such as fentanyl and its newer analogs have been used. However, the use of narcotics is associated with certain side effects. Objectives: This study compares the effects of labetalol and remifentanil in pain control after bariatric surgery in Hazrat Rasool Akram Hospital. Methods: This randomized, double-blind clinical trial was conducted on 48 laparoscopic bariatric surgery patients. The participants were randomly divided into two groups receiving remifentanil or labetalol. Postoperative pain was measured in the recovery unit using the numerical rating scale (NRS). This score was recorded upon entering recovery, and 30 minutes, 60 minutes, and 120 minutes after surgery for each patient. Also, the duration of anesthesia, the duration of the operation, the recovery time, the dose of the administered opioids, the volume of intravenous fluids, and the dose of administered propofol were recorded for each patient. Nausea and vomiting after the operation were also recorded as outcomes. Results: There were no significant differences between the two groups regarding the mean duration of surgery and anesthesia, dose of the administered anesthetics, recovery period, nausea and vomiting, and the dose of analgesics after the operation. The mean pain intensity during the given period and also the trend of pain intensity changes between the two groups demonstrated no statistically significant differences (P = 0.112). During the operation, 9 subjects (37.5%) in the labetalol group and 16 (66.7%) in the remifentanil group needed more analgesics (rescue drug); in this regard, a significant difference was observed between the two groups (P = 0.043). Conclusions: Based on the study’s findings, there were no significant differences between labetalol and remifentanil in post and perioperative pain control. However, rescue drugs needed to maintain hemodynamic stability during laparoscopic surgery were significantly lower in patients who received labetalol than remifentanil. Postoperative complications were also comparable between labetalol and remifentanil. |
| doi_str_mv | 10.5812/aapm-138220 |
| format | article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_5812_aapm_138220</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_5812_aapm_138220</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1760-a76a988ad3a04483d68bea870dafd6fd58f4da285c96137cc4e5a6a79673106e3</originalsourceid><addsrcrecordid>eNo9kM1KAzEYRYMoWGpXvkD2MpqfmSRd1qFaYUCxuh6-Jl9qZP7IpELf3g4VV_deuJzFIeSWs_vCcPEAMLQZl0YIdkFmQgiT6ULyy_8u5DVZjOM3Y4xzlhcqn5H9ipZ9O0CEFH6QbtPBHWnvafpCuvYebZpWBTtM0PQNhc7Rd2yDxy5BFxrad_QNQneidCmeDiufMNJHiAFSDJZuD3GP8XhDrjw0Iy7-ck4-n9Yf5SarXp9fylWVWa4Vy0ArWBoDTgLLcyOdMjsEo5kD75R3hfG5A2EKu1RcamtzLECBXiotOVMo5-TuzLWxH8eIvh5iaCEea87qSVM9aarPmuQvsoZbWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A Comparative Study of the Effect of Labetalol and Remifentanil on Pain Control After Bariatric Surgery</title><source>PubMed Central</source><creator>Mohseni, Masood ; Farahmand Rad, Reza ; Jafarian, Ali Akbar ; Rostami, Mojtaba ; Khosravi, Niloofar</creator><creatorcontrib>Mohseni, Masood ; Farahmand Rad, Reza ; Jafarian, Ali Akbar ; Rostami, Mojtaba ; Khosravi, Niloofar</creatorcontrib><description>Background: Finding the optimal combination of anesthetics to maintain hemodynamic stability during surgery can be challenging. Traditionally, strong opioid analgesics such as fentanyl and its newer analogs have been used. However, the use of narcotics is associated with certain side effects. Objectives: This study compares the effects of labetalol and remifentanil in pain control after bariatric surgery in Hazrat Rasool Akram Hospital. Methods: This randomized, double-blind clinical trial was conducted on 48 laparoscopic bariatric surgery patients. The participants were randomly divided into two groups receiving remifentanil or labetalol. Postoperative pain was measured in the recovery unit using the numerical rating scale (NRS). This score was recorded upon entering recovery, and 30 minutes, 60 minutes, and 120 minutes after surgery for each patient. Also, the duration of anesthesia, the duration of the operation, the recovery time, the dose of the administered opioids, the volume of intravenous fluids, and the dose of administered propofol were recorded for each patient. Nausea and vomiting after the operation were also recorded as outcomes. Results: There were no significant differences between the two groups regarding the mean duration of surgery and anesthesia, dose of the administered anesthetics, recovery period, nausea and vomiting, and the dose of analgesics after the operation. The mean pain intensity during the given period and also the trend of pain intensity changes between the two groups demonstrated no statistically significant differences (P = 0.112). During the operation, 9 subjects (37.5%) in the labetalol group and 16 (66.7%) in the remifentanil group needed more analgesics (rescue drug); in this regard, a significant difference was observed between the two groups (P = 0.043). Conclusions: Based on the study’s findings, there were no significant differences between labetalol and remifentanil in post and perioperative pain control. However, rescue drugs needed to maintain hemodynamic stability during laparoscopic surgery were significantly lower in patients who received labetalol than remifentanil. Postoperative complications were also comparable between labetalol and remifentanil.</description><identifier>ISSN: 2228-7523</identifier><identifier>EISSN: 2228-7531</identifier><identifier>DOI: 10.5812/aapm-138220</identifier><language>eng</language><ispartof>Anesthesiology and pain medicine, 2023-08, Vol.13 (4)</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1760-a76a988ad3a04483d68bea870dafd6fd58f4da285c96137cc4e5a6a79673106e3</cites><orcidid>0000-0002-7274-9817 ; 0000-0003-2783-6652 ; 0000-0001-7756-2878</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids></links><search><creatorcontrib>Mohseni, Masood</creatorcontrib><creatorcontrib>Farahmand Rad, Reza</creatorcontrib><creatorcontrib>Jafarian, Ali Akbar</creatorcontrib><creatorcontrib>Rostami, Mojtaba</creatorcontrib><creatorcontrib>Khosravi, Niloofar</creatorcontrib><title>A Comparative Study of the Effect of Labetalol and Remifentanil on Pain Control After Bariatric Surgery</title><title>Anesthesiology and pain medicine</title><description>Background: Finding the optimal combination of anesthetics to maintain hemodynamic stability during surgery can be challenging. Traditionally, strong opioid analgesics such as fentanyl and its newer analogs have been used. However, the use of narcotics is associated with certain side effects. Objectives: This study compares the effects of labetalol and remifentanil in pain control after bariatric surgery in Hazrat Rasool Akram Hospital. Methods: This randomized, double-blind clinical trial was conducted on 48 laparoscopic bariatric surgery patients. The participants were randomly divided into two groups receiving remifentanil or labetalol. Postoperative pain was measured in the recovery unit using the numerical rating scale (NRS). This score was recorded upon entering recovery, and 30 minutes, 60 minutes, and 120 minutes after surgery for each patient. Also, the duration of anesthesia, the duration of the operation, the recovery time, the dose of the administered opioids, the volume of intravenous fluids, and the dose of administered propofol were recorded for each patient. Nausea and vomiting after the operation were also recorded as outcomes. Results: There were no significant differences between the two groups regarding the mean duration of surgery and anesthesia, dose of the administered anesthetics, recovery period, nausea and vomiting, and the dose of analgesics after the operation. The mean pain intensity during the given period and also the trend of pain intensity changes between the two groups demonstrated no statistically significant differences (P = 0.112). During the operation, 9 subjects (37.5%) in the labetalol group and 16 (66.7%) in the remifentanil group needed more analgesics (rescue drug); in this regard, a significant difference was observed between the two groups (P = 0.043). Conclusions: Based on the study’s findings, there were no significant differences between labetalol and remifentanil in post and perioperative pain control. However, rescue drugs needed to maintain hemodynamic stability during laparoscopic surgery were significantly lower in patients who received labetalol than remifentanil. Postoperative complications were also comparable between labetalol and remifentanil.</description><issn>2228-7523</issn><issn>2228-7531</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo9kM1KAzEYRYMoWGpXvkD2MpqfmSRd1qFaYUCxuh6-Jl9qZP7IpELf3g4VV_deuJzFIeSWs_vCcPEAMLQZl0YIdkFmQgiT6ULyy_8u5DVZjOM3Y4xzlhcqn5H9ipZ9O0CEFH6QbtPBHWnvafpCuvYebZpWBTtM0PQNhc7Rd2yDxy5BFxrad_QNQneidCmeDiufMNJHiAFSDJZuD3GP8XhDrjw0Iy7-ck4-n9Yf5SarXp9fylWVWa4Vy0ArWBoDTgLLcyOdMjsEo5kD75R3hfG5A2EKu1RcamtzLECBXiotOVMo5-TuzLWxH8eIvh5iaCEea87qSVM9aarPmuQvsoZbWg</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Mohseni, Masood</creator><creator>Farahmand Rad, Reza</creator><creator>Jafarian, Ali Akbar</creator><creator>Rostami, Mojtaba</creator><creator>Khosravi, Niloofar</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-7274-9817</orcidid><orcidid>https://orcid.org/0000-0003-2783-6652</orcidid><orcidid>https://orcid.org/0000-0001-7756-2878</orcidid></search><sort><creationdate>20230801</creationdate><title>A Comparative Study of the Effect of Labetalol and Remifentanil on Pain Control After Bariatric Surgery</title><author>Mohseni, Masood ; Farahmand Rad, Reza ; Jafarian, Ali Akbar ; Rostami, Mojtaba ; Khosravi, Niloofar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1760-a76a988ad3a04483d68bea870dafd6fd58f4da285c96137cc4e5a6a79673106e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Mohseni, Masood</creatorcontrib><creatorcontrib>Farahmand Rad, Reza</creatorcontrib><creatorcontrib>Jafarian, Ali Akbar</creatorcontrib><creatorcontrib>Rostami, Mojtaba</creatorcontrib><creatorcontrib>Khosravi, Niloofar</creatorcontrib><collection>CrossRef</collection><jtitle>Anesthesiology and pain medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohseni, Masood</au><au>Farahmand Rad, Reza</au><au>Jafarian, Ali Akbar</au><au>Rostami, Mojtaba</au><au>Khosravi, Niloofar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Comparative Study of the Effect of Labetalol and Remifentanil on Pain Control After Bariatric Surgery</atitle><jtitle>Anesthesiology and pain medicine</jtitle><date>2023-08-01</date><risdate>2023</risdate><volume>13</volume><issue>4</issue><issn>2228-7523</issn><eissn>2228-7531</eissn><abstract>Background: Finding the optimal combination of anesthetics to maintain hemodynamic stability during surgery can be challenging. Traditionally, strong opioid analgesics such as fentanyl and its newer analogs have been used. However, the use of narcotics is associated with certain side effects. Objectives: This study compares the effects of labetalol and remifentanil in pain control after bariatric surgery in Hazrat Rasool Akram Hospital. Methods: This randomized, double-blind clinical trial was conducted on 48 laparoscopic bariatric surgery patients. The participants were randomly divided into two groups receiving remifentanil or labetalol. Postoperative pain was measured in the recovery unit using the numerical rating scale (NRS). This score was recorded upon entering recovery, and 30 minutes, 60 minutes, and 120 minutes after surgery for each patient. Also, the duration of anesthesia, the duration of the operation, the recovery time, the dose of the administered opioids, the volume of intravenous fluids, and the dose of administered propofol were recorded for each patient. Nausea and vomiting after the operation were also recorded as outcomes. Results: There were no significant differences between the two groups regarding the mean duration of surgery and anesthesia, dose of the administered anesthetics, recovery period, nausea and vomiting, and the dose of analgesics after the operation. The mean pain intensity during the given period and also the trend of pain intensity changes between the two groups demonstrated no statistically significant differences (P = 0.112). During the operation, 9 subjects (37.5%) in the labetalol group and 16 (66.7%) in the remifentanil group needed more analgesics (rescue drug); in this regard, a significant difference was observed between the two groups (P = 0.043). Conclusions: Based on the study’s findings, there were no significant differences between labetalol and remifentanil in post and perioperative pain control. However, rescue drugs needed to maintain hemodynamic stability during laparoscopic surgery were significantly lower in patients who received labetalol than remifentanil. Postoperative complications were also comparable between labetalol and remifentanil.</abstract><doi>10.5812/aapm-138220</doi><orcidid>https://orcid.org/0000-0002-7274-9817</orcidid><orcidid>https://orcid.org/0000-0003-2783-6652</orcidid><orcidid>https://orcid.org/0000-0001-7756-2878</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2228-7523 |
| ispartof | Anesthesiology and pain medicine, 2023-08, Vol.13 (4) |
| issn | 2228-7523 2228-7531 |
| language | eng |
| recordid | cdi_crossref_primary_10_5812_aapm_138220 |
| source | PubMed Central |
| title | A Comparative Study of the Effect of Labetalol and Remifentanil on Pain Control After Bariatric Surgery |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T17%3A47%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Comparative%20Study%20of%20the%20Effect%20of%20Labetalol%20and%20Remifentanil%20on%20Pain%20Control%20After%20Bariatric%20Surgery&rft.jtitle=Anesthesiology%20and%20pain%20medicine&rft.au=Mohseni,%20Masood&rft.date=2023-08-01&rft.volume=13&rft.issue=4&rft.issn=2228-7523&rft.eissn=2228-7531&rft_id=info:doi/10.5812/aapm-138220&rft_dat=%3Ccrossref%3E10_5812_aapm_138220%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1760-a76a988ad3a04483d68bea870dafd6fd58f4da285c96137cc4e5a6a79673106e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |